Related Research Articles
Michael Smith was a British-born Canadian biochemist and businessman. He shared the 1993 Nobel Prize in Chemistry with Kary Mullis for his work in developing site-directed mutagenesis. Following a PhD in 1956 from the University of Manchester, he undertook postdoctoral research with Har Gobind Khorana at the British Columbia Research Council in Vancouver, British Columbia, Canada. Subsequently, Smith worked at the Fisheries Research Board of Canada Laboratory in Vancouver before being appointed a professor of biochemistry in the UBC Faculty of Medicine in 1966. Smith's career included roles as the founding director of the UBC Biotechnology Laboratory and the founding scientific leader of the Protein Engineering Network of Centres of Excellence (PENCE). In 1996 he was named Peter Wall Distinguished Professor of Biotechnology. Subsequently, he became the founding director of the Genome Sequencing Centre at the BC Cancer Research Centre.
Andrzej Viktor "Andrew" Schally is an American endocrinologist of Polish ancestry, who was a corecipient, with Roger Guillemin and Rosalyn Sussman Yalow, of the Nobel Prize in Physiology or Medicine. This award recognized his research in the discovery that the hypothalamus controls hormone production and release by the pituitary gland, which controls the regulation of other hormones in the body. Later in life, Schally utilized his knowledge of hypothalamic hormones to research possible methods for birth control and cancer treatment.
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".
Edward Donnall "Don" Thomas was an American physician, professor emeritus at the University of Washington, and director emeritus of the clinical research division at the Fred Hutchinson Cancer Research Center. In 1990 he shared the Nobel Prize in Physiology or Medicine with Joseph E. Murray for the development of cell and organ transplantation. Thomas and his wife and research partner Dottie Thomas developed bone marrow transplantation as a treatment for leukemia.
Charles H. Hollenberg was a Canadian physician, educator and researcher.
Mani Menon, born 9 July 1948 in Trichur, India, is an American surgeon whose pioneering work has helped to lay the foundation for modern Robotic Cancer Surgery. He is the founding director and the Raj and Padma Vattikuti Distinguished Chair of the Vattikuti Urology Institute at the Henry Ford Hospital in Detroit, MI, where he established the first cancer-oriented robotics program in the world. Menon is widely regarded for his role in the development of robotic surgery techniques for the treatment of patients with prostate, kidney, and bladder cancers, as well as for the development of robotic kidney transplantation.
Menon is the recipient of the Gold Cystoscope award, Hugh Hampton Young award, the Keyes Medal, the prestigious B.C. Roy award.
Ashutosh K. Tewari is the chairman of urology at the Icahn School of Medicine at Mount Sinai Hospital in New York City. He is a board certified American urologist, oncologist, and principal investigator. Before moving to the Icahn School of Medicine in 2013, he was the founding director of both the Center for Prostate Cancer at Weill Cornell Medical College and the LeFrak Center for Robotic Surgery at NewYork–Presbyterian Hospital. Dr. Tewari was the Ronald P. Lynch endowed Chair of Urologic Oncology and the hospital's Director of Robotic Prostatectomy, treating patients with prostate, urinary bladder and other urological cancers. He is the current President of the Society for Urologic Robotic Surgeons (SURS) and the Committee Chair of the Prostate Program. Dr. Tewari is a world leading urological surgeon, and has performed over 10,000 robotically assisted procedures using the da Vinci Surgical System. Academically, he is recognized as a world-renowned expert on urologic oncology with over 250 peer reviewed published papers to his credit; he is on such lists as America's Top Doctors, New York Magazine's Best Doctors, and Who's Who in the World. In 2012, he was given the American Urological Association Gold Cystoscope Award for "outstanding contributions to the field of urologic oncology, most notably the treatment of prostate cancer and the development of novel techniques to improve the outcomes of robotic prostatectomy."
S. Larry Goldenberg, is a Canadian researcher in the field of medicine and a pioneer in the treatment of prostate cancer.
Joseph W. Cullen was an American cancer prevention and rehabilitation researcher and briefly director of the AMC Cancer Research Center (1989-1990). He previously worked at the VA Hospital in Maryland (1968-1973), the National Institutes of Health (1973), the National Cancer Institute (NCI), and the Jonsson Comprehensive Cancer Center (1976-1982), holding high-level positions such as division director at several. He was a coordinator, creator, and researcher for the Smoking Tobacco and Cancer Program at the NCI, the largest anti-smoking campaign in the world at that time. Cullen wrote more than 90 publications in his lifetime, including four books.
Donald Blake Rix, was a Canadian pathologist, philanthropist, community volunteer, and businessman. He was the founder and chair of MDS Metro Laboratory Services, the largest private medical laboratory in Western Canada.
Judy Illes,, PHD, FRSC, FCAHS, is Professor of Neurology and Distinguished University Scholar in Neuroethics at the University of British Columbia. She is Director of Neuroethics Canada at UBC, and faculty in the Brain Research Centre at UBC and at the Vancouver Coastal Health Research Institute. She also holds affiliate appointments in the School of Population and Public Health and the School of Journalism at UBC, and in the Department of Computer Science and Engineering at the University of Washington in Seattle, WA. USA. She was appointed a member of the Order of Canada in 2017.
Moira Stilwell is a Canadian politician, who was elected as a member of the Legislative Assembly of British Columbia in 2009 to represent the riding of Vancouver-Langara until 2017. She was appointed parliamentary secretary for industry, research and innovation to the Minister of Jobs, Tourism and Innovation on March 14, 2011. She served as Minister of Advanced Education and Labour Market Development in the government of B.C. from June 2009 to October 2010 when she was appointed Minister of Regional Economic and Skills Development.
Roger Sinclair Kirby FRCS(Urol), FEBU is a British retired prostate surgeon and professor of urology, researcher, writer on men's health and prostate disease, founding editor of the journal Prostate Cancer and Prostatic Diseases and Trends in Urology and Men's Health and a fundraiser for prostate disease charities, best known for his use of the da Vinci surgical robot for laparoscopic prostatectomy in the treatment of prostate cancer. He is a co-founder and president of the charity The Urology Foundation (TUF), vice-president of the charity Prostate Cancer UK, trustee of the King Edward VII's Hospital and as of 2020 is president of the Royal Society of Medicine (RSM), London.
Michael R. Hayden, is a Killam Professor of Medical Genetics at the University of British Columbia, the highest honour UBC can confer on any faculty member. Only four such awards have ever been conferred in the Faculty of Medicine. Dr. Hayden is also Canada Research Chair in Human Genetics and Molecular Medicine. Hayden is best known for his research in Huntington disease (HD).
The Vancouver Prostate Centre (VPC) is a prostate cancer translational research centre located in Vancouver, British Columbia. It is a UBC and VGH Centre of Excellence and a designated national Centre of Excellence for Commercialization and Research. The VPC is hosted by the Vancouver Coastal Health Research Institute and the Department of Urologic Sciences, Faculty of Medicine, University of British Columbia.
Julio S. G. Montaner, is an Argentine-Canadian physician, professor and researcher. He is the director of the British Columbia Centre for Excellence in HIV/AIDS, the chair in AIDS Research and head of the Division of AIDS in the Faculty of Medicine at the University of British Columbia and the past-president of the International AIDS Society. He is also the director of the John Ruedy Immunodeficiency Clinic, and the Physician Program Director for HIV/AIDS PHC. He is known for his work on HAART, a role in the discovery of triple therapy as an effective treatment for HIV in the late 1990s, and a role in advocating the "Treatment as Prevention" Strategy in the mid-2000s, led by Myron Cohen of the HPTN 052 trial.
Frances Alice Shepherd, is a Canadian oncologist recognized for her research on lung cancer and her contributions to the design, development, and conduct of clinical trials. She is currently a senior staff physician at Princess Margaret Cancer Centre, where she has held the Scott Taylor Chair in Lung Cancer Research since 2001, and she is a full professor in the Department of Medicine at the University of Toronto.
Perry Kendall, is a Canadian Public health physician who was Provincial Health Officer (PHO) for the Canadian province of British Columbia's health ministry from 1999-2018 and was awarded the Order of British Columbia for contributions to Public health field and to harm reduction policy and practice.
Nadine Rena Caron FACS, FRCSC,, is a Canadian surgeon. She is the first Canadian female general surgeon of First Nations descent (Ojibway), as well as the first female First Nations student to graduate from University of British Columbia's medical school.
Amina Zoubeidi is a Canadian research scientist and prostate cancer researcher. She's a scientist at the Vancouver Coastal Health Research Institute and an associate professor in the Department of Urologic Sciences at the University of British Columbia. During her tenure at UBC, Zoubeidi and her research team developed the first drug that targets and blocks BRN2, thus stopping Neuroendocrine prostate cancer (NEPC) tumours and creating a possible treatment for the previously thought incurable disease.
References
- ↑ Li, Wanyee (January 4, 2018). "B.C. doctor inducted into Order of Canada for innovative cancer treatments". Metro News Vancouver. Retrieved January 10, 2018.
- ↑ Crawford, Tiffany (August 28, 2010). "New cancer drug will prolong lives, Vancouver scientists say". Vancouver Sun. Retrieved 9 January 2018.
- 1 2 3 4 5 "DR. MARTIN GLEAVE APPOINTED TO THE ORDER OF CANADA". Vancouver Coastal Health Research Institute. Retrieved January 9, 2018.
- ↑ "AJT Prize Recognizes Made-In-BC Advances In Prostate Cancer Treatment". msfhr.org. Retrieved January 9, 2018.
   | This biography related to medicine in Canada is a stub. You can help Wikipedia by expanding it. |